Precision Oncology Study in Breast Cancer (PRISM)
Part of Cancer, Skin clinical trials.
This study looks at tumor tissue from people with breast cancer, including those with brain metastases. It aims to learn more about the genetic changes in the cancer to help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that has been confirmed by a biopsy or surgery.
- You are having surgery to remove your breast tumor, or you are receiving neoadjuvant treatment (such as chemotherapy or hormone therapy) before surgery.
- You are 18 years old or older.
- You are able to give informed consent (understand and agree to join the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic material from spinal fluid to better understand breast cancer that has spread to the brain or its lining. It may help doctors find new ways to treat this type of cancer.
This study tests personalized, changing treatment plans (given before surgery) to find better options for your specific breast tumor. You may be asked for extra breast-tissue testing to help match you with the most suitable study drug(s).
This study tests an investigational cellular immunotherapy called BRIA-OTS for people with metastatic breast cancer that has spread and is no longer responding to standard treatments. It aims to help the immune system fight cancer cells.
This trial studies your tumor’s gene activity and breast cancer subtype to help guide treatment choices. It mainly looks at whether analyzing “RNA expression” and tumor subtype can improve how therapy is optimized during metastatic breast cancer care.
This study tests a new drug called BMS-986507, given in different combinations, for people with advanced solid tumors (lung cancer or breast cancer that has spread). It looks at safety, how the drug works in the body, and if it helps shrink tumors.
This trial looks at breast cancer “proteins” and molecular features using tumor samples taken during surgery or biopsy. The goal is to better understand why breast cancers behave differently, which may help guide more personalized treatment in the future.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.